Preliminary scientific tests point out conolidine may possibly inhibit specific ion channels, lowering neuronal excitability and limiting discomfort indicators. This system is especially suitable in neuropathic discomfort, where by abnormal signaling leads to persistent discomfort. Moreover, conolidine seems to affect G protein-coupled receptor (GP